.jpg)
ABOUT HOOMYA
关于宏雅
湖南宏雅基因技术有限公司是由临床药理学家、我国遗传药理学与药物基因组学的开拓者和奠基人、个体化医学的倡导者和引领者周宏灏院士及其团队发起设立，致力于个体化医学（精准医学）检测技术的研究与产业化的高科技公司。公司主要从事个体化医学检测产品（含产品科研、CDMO、仪器与设备、试剂耗材及检测服务）的开发、运营与市场推广，打造精准医学时代的专业个体化医学检测运营服务平台.
公司联合以湘雅医学检验所为主体的国内外多家个体化医学（精准医学)专业研究机构，引进顶尖学者、
美国墨菲特癌症中心医学主任霍华德 · L · 麦克劳德为代表的专家技术团队，整合国内外先进的个体化医学检测技术平台，
以研发带动生产和销售，依托具有先进性的分子诊断核心技术，在体外诊断，尤其是高端的分子诊断领域形成了
一系列具有自主知识产权的产品。
The company has joined forces with a number of Personalized medicine (precision medicine) professional research institutes at home and abroad, mainly based on the Xiangya medical laboratory, howard L. McCloud, medical director of the Murphy Cancer Center in the United States and a leading scholar, was brought in to represent the expert and technical team to integrate advanced Personalized medicine detection technology platforms at home and abroad, a series of products with independent intellectual property rights have been developed in the field of in vitro diagnosis, especially in high-end molecular diagnosis.
公司目前主营业务包括各类应用于无创产前筛查、疾病预测、疾病早期筛查、疾病早期分子诊断与分
子分型、疾病个体化用药指导、疾病预后监测的分子检测产品，已形成覆盖全国的营销网络，成为个体化
医学（精准医学）专业服务领域的优势品牌企业。
At present, the company's main business includes various applications in non-invasive prenatal screening, disease prediction, disease early screening, disease early molecular diagnosis and classification, the molecular detection products of sub-typing, disease individualized medication guidance and disease prognosis monitoring have formed a nationwide marketing network and become individualized, medical (precision medicine) professional services in the field of dominant brand enterprises
公司联合以湘雅医学检验所为主体的国内外多家个体化医学（精准医学）专业研究机构，引进以
顶尖学者、美国墨菲特癌症中心医学主任霍华德 · L · 麦克劳德d为代表的专家技术团队，整合
国内外先进的个体化医学检测技术平台，以研发带动生产和销售，依托具有先进性的分子诊断核心技术，
在体外诊断，尤其是高端的分子诊断领域形成了一系列具有自主知识产权的产品。
The company has teamed up with a number of Personalized medicine (precision medicine) professional research institutes at home and abroad, mainly based on the Xiangya medical laboratory, howard L. McCloud D, medical director of the Murphy Cancer Center and a leading scholar, is the representative of the expert and technical team, which integrates the advanced Personalized medicine detection technology platform at home and abroad, in vitro diagnosis, especially in high-end molecular diagnosis field, has formed a series of products with independent intellectual property rights, relying on advanced molecular diagnosis core technology.
公司目前主营业务包括各类应用于无创产前筛查、疾病预测、疾病早期筛查、疾病早期分子诊断与分子
分型、疾病个体化用药指导、疾病预后监测的分子检测产品，业务版图已遍布湖南、湖北、江苏、浙
江、安徽、上海、北京、天津、河南、河北、山东、山西、陕西、辽宁、广东、广西、云南、
贵州等地区。
At present, the company's main business includes various applications in non-invasive prenatal screening, disease prediction, disease early screening, disease early molecular diagnosis and molecular, molecular testing products for typing, individualized medication guidance, and disease prognosis monitoring, the business scope has spread over Hunan, Hubei, Jiangsu, Zhejiang, Anhui, Shanghai, Beijing, Tianjin, Henan, Hebei, Shandong, Shanxi, Shaanxi, Liaoning, Guangdong, Guangxi, Yunnan, Guizhou and other regions.
个体化医学Personalized Medicine
个体化医学是21世纪医学发展的必然趋势。随着人类基因组计划的完成和后基因组学的深入研究， 越来越多的致病基因被定位，更多疾病发生的遗传学基础得以阐明，与人类生理、病理以及药物效应 和毒副反应相关的基因特征不断被揭示，促使医学模式由经典的基于规律总结的“标准化医学”，向基 于个体基因差异进行的“量体裁衣”式的“个体化医学”转变。个体化医学是根据个体的基因信息对疾病 进行诊断、治疗和风险评估，使疾病的诊治更为精确、高效，显著提升医疗质量。个体化医学目前发 展最为成熟的领域是个体化用药，即以每个患者的基因信息为基础决定个人的药物治疗方案，从基因 组成或表达的差异来预测疾病的治疗效果或毒副作用，对每个患者选择最适宜的药物疗法进行治疗。 个体化医学弥补了循证医学的缺点，其治疗更有针对性，可以按照个体对某种特定疾病易感性的不同 或对某种特定治疗反应性的不同，把人群分为不同的亚群，进而对患者进行有效地预防或治疗性干预， 节约医疗费用和避免毒副反应Personalized medicine is an inevitable trend in the development of medicine in the 21st century.With the completion of the human genome project and in-depth research on post-genomics, more and more disease-causing genes have been located, and the genetic basis of more diseases has been elucidated, which is related to human physiology, pathology, drug effects and toxic side effects. Gene characteristics are constantly being revealed, prompting the medical model to change from the classic "standardized medicine" based on rule summaries to "tailor-made" "individualized medicine" based on individual genetic differences.Personalized medicine is the diagnosis, treatment and risk assessment of diseases based on individual genetic information, making the diagnosis and treatment of diseases more accurate and efficient, and significantly improving the quality of medical care.The most mature field of personalized medicine is personalized medicine, which determines individual drug treatment plans based on each patient'。
个体化医学检测Personalized Medicine
通过利用专业检测仪器平台和配套的试剂、耗材，检测与疾病的发生和用药相关基因的结构改变、表达 和代谢变化等，进一步使用数据库、分析模型、软件等工具对检测结果进行专业分析并对分析结果进行专业 咨询（针对受检者及其医生），对疾病进行个性化的预测、诊断、治疗决策和检测的临床检测服务。